Cargando…
Defining a TCF1-expressing progenitor allogeneic CD8(+) T cell subset in acute graft-versus-host disease
Graft-versus-host disease (GvHD) is a severe complication of hematopoietic stem cell transplantation driven by activated allogeneic T cells. Here, we identify a distinct subset of T cell factor-1 (TCF1)(+) CD8(+) T cells in mouse allogeneic and xenogeneic transplant models of acute GvHD. These TCF1(...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516895/ https://www.ncbi.nlm.nih.gov/pubmed/37737221 http://dx.doi.org/10.1038/s41467-023-41357-9 |
Sumario: | Graft-versus-host disease (GvHD) is a severe complication of hematopoietic stem cell transplantation driven by activated allogeneic T cells. Here, we identify a distinct subset of T cell factor-1 (TCF1)(+) CD8(+) T cells in mouse allogeneic and xenogeneic transplant models of acute GvHD. These TCF1(+) cells exhibit distinct characteristics compared to TCF1(-) cells, including lower expression of inhibitory receptors and higher expression of costimulatory molecules. Notably, the TCF1(+) subset displays exclusive proliferative potential and could differentiate into TCF1(-) effector cells upon antigenic stimulation. Pathway analyses support the role of TCF1(+) and TCF1(-) subsets as resource cells and effector cells, respectively. Furthermore, the TCF1(+) CD8(+) T cell subset is primarily present in the spleen and exhibits a resident phenotype. These findings provide insight into the differentiation of allogeneic and xenogeneic CD8(+) T cells and have implications for the development of immunotherapeutic strategies targeting acute GvHD. |
---|